* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
HKSE:01889 vs ZTS, UTHR, VTRS: OCF Margin % Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Sanai Health Industry Group Co's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sanai Health Industry Group Co OCF Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Sanai Health Industry Group Co's OCF Margin % distribution charts can be found below:
* The bar in red indicates where Sanai Health Industry Group Co's OCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sanai Health Industry Group Co (HKSE:01889) has a OCF Margin % of -123.86% as of Dec. 2025. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Sanai Health Industry Group Co and its competitors. According to the industry distribution chart, Sanai Health Industry Group Co ranks #876 out of 959 companies in the Drug Manufacturers industry, placing it in the top 91.3%.
Is Sanai Health Industry Group Co's OCF Margin % too high?
Sanai Health Industry Group Co's current OCF Margin % is -123.86%. Based on the distribution chart, Sanai Health Industry Group Co ranks #876 out of 959 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Sanai Health Industry Group Co has a GF Score™ of 40/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Sanai Health Industry Group Co's OCF Margin % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Sanai Health Industry Group Co ranks #876 out of 959 companies for OCF Margin %. This places Sanai Health Industry Group Co in the lower half of its industry. The industry median OCF Margin % is 9.95. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Drug Manufacturers company?
The median OCF Margin % among Drug Manufacturers companies is 9.95, based on 959 companies in the industry. Companies in the top quartile (top 25%) have a OCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Sanai Health Industry Group Co and its competitors. For the Drug Manufacturers industry, the median OCF Margin % is 9.95 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sanai Health Industry Group Co's current OCF Margin % is -123.86%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sanai Health Industry Group Co stock overvalued right now?
Based on GuruFocus' analysis, Sanai Health Industry Group Co (HKSE:01889) is currently considered Possible Value Trap. The stock's GF Value™ is HK$0.43, compared to a current price of HK$0.21 — trading 51.2% below its estimated fair value. The current OCF Margin % is -123.86%. Sanai Health Industry Group Co's overall GF Score™ is 40/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Sanai Health Industry Group Co (HKSE:01889), the current OCF Margin % is -123.86% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Sanai Health Industry Group Co (HKSE:01889) Overvalued in 2026?
Based on GuruFocus' analysis, Sanai Health Industry Group Co stock appears to be undervalued.
The current stock price of HK$0.21 is trading 51.2% below its estimated GF Value™ of HK$0.43.
GuruFocus considers Sanai Health Industry Group Co to be Possible Value Trap.
Key valuation signals for HKSE:01889:
OCF Margin %: -123.86%
GF Value™: HK$0.43 vs. price of HK$0.21 (51.2% below fair value)
No single metric tells the full story. See the HKSE:01889 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Sanai Health Industry Group Co Business Description
Sanai Health Industry Group Co Ltd is a pharmaceutical company. The company has three reportable segments namely Pharmaceutical products include development, manufacturing, marketing, and sales of pharmaceutical products and related software and provision of consultancy services. Finance leasing includes the provision of financial leasing services; Genetic testing and molecular diagnostic services segment. It generates maximum revenue from Pharmaceutical products segments. Geographically, it derives the majority of its revenue from the PRC.
40GF Score
Get the complete analysis for HKSE:01889
OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:01889 has been successfully added to your 
